# OnCo record caix-pet (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/caix-pet/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "caix-pet" ;
  schema:name "CAIX PET (89Zr-girentuximab)"@en ;
  schema:description "CAIX PET is a scan using an antibody against a protein almost unique to clear-cell kidney cancer, to tell cancer from benign kidney lumps without a biopsy."@en ;
  schema:url <https://onco.cc/technologies/caix-pet/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S1470-2045(24)00402-9> ;
  onco:status "phase-3" ;
  onco:cancers <https://onco.cc/cancers/rcc/> ;
  onco:sections <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/immuno-pet/>, <https://onco.cc/technologies/pet/> ;
  onco:targets <https://onco.cc/targets/hif2a/> ;
  onco:companies <https://onco.cc/companies/telix/> ;
  onco:pathways <https://onco.cc/pathways/hif-vhl/> ;
  onco:trials <https://onco.cc/trials/nct06750419/>, <https://onco.cc/trials/nct03849118/>, <https://onco.cc/trials/nct06447103/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-shuch-lancet-oncol/> .